Available CD4 cell measurements, frequency and follow-up time of 1959 seroconverters from European and sub-Saharan African (SSA) cohorts.

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India

Rajasekaran, S.
Jeyaseelan, L.
Raja, K.
Vijila, S.
Krithigaipriya, K. A.
Kuralmozhi, R.

October 2010

Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Nikos Pantazis
Charles Morrison
Pauli N Amornkul
Charlotte Lewden
Robert A Salata
Albert Minga
Tsungai Chipato
Harold Jaffe
Shabir Lakhi
Etienne Karita
Kholoud Porter
Laurence Meyer
Giota Touloumi

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeDEA West Africa collaboration.

Didier K. Ekouevi (127416)
Eric Balestre (199601)
Patrick A. Coffie (530427)
Daouda Minta (587065)
Eugene Messou (3697207)
Adrien Sawadogo (587066)
Albert Minga (330446)
Papa Salif Sow (135540)
Emmanuel Bissagnene (127445)
Serge P. Eholie (127440)
Geoffrey S. Gottlieb (235246)
François Dabis (78475)

June 2013

<p>Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

CASCADE Collaboration

January 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg, Nanina
Panayidou, Klea
Abo, Yao
Alejos, Belen
Althoff, Keri N.
Anastos, Kathryn
Antinori, Andrea
Balestre, Eric
Becquet, Renaud
Castagna, Antonella
Castelnuovo, Barbara
Chêne, Geneviève
Coelho, Lara
Collins, Intira Jeannie
Costagliola, Dominique
Crabtree-Ramírez, Brenda
Dabis, Francois
D'Arminio Monforte, Antonella
Davies, Mary-Ann
de Wit, Stéphane
Delpech, Valérie
de La Mata, Nicole L.
Duda, Stephany
Freeman, Aimee
Gange, Stephen J.
Grabmeier-Pfistershammer, Katharina
Gunsenheimer-Bartmeyer, Barbara
Jiamsakul, Awachana
Kitahata, Mari M.
Law, Matthew
Manzardo, Christian
McGowan, Catherine
Meyer, Laurence
Moore, Richard
Mussini, Cristina
Nakigoz, Gertrude
Nash, Denis
tek Ng, Oon
Obel, Niels
Pantazis, Nikos
Poda, Armel
Raben, Dorthe
Reiss, Peter
Riggen, Larry
Sabin, Caroline
d'Amour Sinayobye, Jean
Sönnerborg, Anders
Stoeckle, Marcel
Thorne, Claire
Torti, Carlo

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

Bouteloup, V.
Sabin, C.
Mocroft, A.
Gras, L.
Pantazis, N.
Le Moing, V.
d'Arminio Monforte, A.
Mary-Krause, M.
Roca, B.
Miro, J. M.
Battegay, M.
Brockmeyer, N.
Berenguer, J.
Morlat, P.
Obel, N.
de Wit, S.
Fätkenheuer, G.
Zangerle, R.
Ghosn, J.
Pérez-Hoyos, S.
Campbell, M.
Prins, M. [= Maria]
Chêne, G.
Meyer, L.
Dorrucci, M.
Torti, C.
Thiébaut, R.

January 2017

The aim of this work was to provide a reference for the CD4 T-cell count response in the early month...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

September 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg N
Panayidou K
Abo Y
Alejos B
Althoff KN
Anastos K
Antinori A
Balestre E
Becquet R
Castagna A
Castelnuovo B
Chêne G
Coelho L
Collins IJ
Costagliola D
Crabtree-Ramírez B
Dabis F
d'Arminio Monforte A
Davies MA
De Wit S
Delpech V
De La Mata NL
Duda S
Freeman A
Gange SJ
Grabmeier-Pfistershammer K
Gunsenheimer-Bartmeyer B
Jiamsakul A
Kitahata MM
Law M
Manzardo C
McGowan C
Meyer L
Moore R
Mussini C
Nakigoz G
Nash D
Tek Ng O
Obel N
Pantazis N
Poda A
Raben D
Reiss P
Riggen L
Sabin C
d'Amour Sinayobye J
Sönnerborg A
Stoeckle M
Thorne C
Torti C
Twizere C
Wasmuth JC
Wittkop L
Wools-Kaloustian K
Yotebieng M
Kirk O
Egger M.

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.

Babiker, A
Darbyshire, J
Pezzotti, P
Porter, K
Prins, M
Sabin, C
Walker, A

January 2003

The effect of HIV infection duration and CD4 cell count on short-term CD4 response was evaluated in ...

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Wolbers, M
Babiker, A
Sabin, C
Young, J
Dorrucci, M
Chêne, G
Mussini, C
Porter, K
Bucher, H

January 2010

BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients

Bouteloup, V.
Sabin, C.
Mocroft, A.
Gras, L.
Pantazis, N.
Le Moing, V.
d'Arminio Monforte, A.
Mary-Krause, M.
Roca, B.
Miro, J. M.
Battegay, M.
Brockmeyer, N.
Berenguer, J.
Morlat, P.
Obel, N.
De Wit, S.
Faetkenheuer, G.
Zangerle, R.
Ghosn, J.
Perez-Hoyos, S.
Campbell, M.
Prins, M.
Chene, G.
Meyer, L.
Dorrucci, M.
Torti, C.
Thiebaut, R.

January 2017

ObjectivesThe aim of this work was to provide a reference for the CD4 T-cell count response in the e...

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa

Pantazis Nikos
Morrison Charles
Amornkul Pauli N.
Lewden Charlotte
Salata Robert A.
Minga Albert
Chipato Tsungai
Jaffe Harold
Lakhi Shabir
Karita Etienne
Porter Kholoud
Meyer Laurence
Touloumi Giota

March 2012

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa

Pantazis Nikos
Morrison Charles
Amornkul Pauli N.
Lewden Charlotte
Salata Robert A.
Minga Albert
Chipato Tsungai
Jaffe Harold
Lakhi Shabir
Karita Etienne
Porter Kholoud
Meyer Laurence
Touloumi Giota

March 2012

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India

Rajasekaran, S.
Jeyaseelan, L.
Raja, K.
Vijila, S.
Krithigaipriya, K. A.
Kuralmozhi, R.

October 2010

Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India

Rajasekaran, S.
Jeyaseelan, L.
Raja, K.
Vijila, S.
Krithigaipriya, K. A.
Kuralmozhi, R.

October 2010

Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Nikos Pantazis
Charles Morrison
Pauli N Amornkul
Charlotte Lewden
Robert A Salata
Albert Minga
Tsungai Chipato
Harold Jaffe
Shabir Lakhi
Etienne Karita
Kholoud Porter
Laurence Meyer
Giota Touloumi

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeDEA West Africa collaboration.

Didier K. Ekouevi (127416)
Eric Balestre (199601)
Patrick A. Coffie (530427)
Daouda Minta (587065)
Eugene Messou (3697207)
Adrien Sawadogo (587066)
Albert Minga (330446)
Papa Salif Sow (135540)
Emmanuel Bissagnene (127445)
Serge P. Eholie (127440)
Geoffrey S. Gottlieb (235246)
François Dabis (78475)

June 2013

<p>Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

CASCADE Collaboration

January 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg, Nanina
Panayidou, Klea
Abo, Yao
Alejos, Belen
Althoff, Keri N.
Anastos, Kathryn
Antinori, Andrea
Balestre, Eric
Becquet, Renaud
Castagna, Antonella
Castelnuovo, Barbara
Chêne, Geneviève
Coelho, Lara
Collins, Intira Jeannie
Costagliola, Dominique
Crabtree-Ramírez, Brenda
Dabis, Francois
D'Arminio Monforte, Antonella
Davies, Mary-Ann
de Wit, Stéphane
Delpech, Valérie
de La Mata, Nicole L.
Duda, Stephany
Freeman, Aimee
Gange, Stephen J.
Grabmeier-Pfistershammer, Katharina
Gunsenheimer-Bartmeyer, Barbara
Jiamsakul, Awachana
Kitahata, Mari M.
Law, Matthew
Manzardo, Christian
McGowan, Catherine
Meyer, Laurence
Moore, Richard
Mussini, Cristina
Nakigoz, Gertrude
Nash, Denis
tek Ng, Oon
Obel, Niels
Pantazis, Nikos
Poda, Armel
Raben, Dorthe
Reiss, Peter
Riggen, Larry
Sabin, Caroline
d'Amour Sinayobye, Jean
Sönnerborg, Anders
Stoeckle, Marcel
Thorne, Claire
Torti, Carlo

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

Bouteloup, V.
Sabin, C.
Mocroft, A.
Gras, L.
Pantazis, N.
Le Moing, V.
d'Arminio Monforte, A.
Mary-Krause, M.
Roca, B.
Miro, J. M.
Battegay, M.
Brockmeyer, N.
Berenguer, J.
Morlat, P.
Obel, N.
de Wit, S.
Fätkenheuer, G.
Zangerle, R.
Ghosn, J.
Pérez-Hoyos, S.
Campbell, M.
Prins, M. [= Maria]
Chêne, G.
Meyer, L.
Dorrucci, M.
Torti, C.
Thiébaut, R.

January 2017

The aim of this work was to provide a reference for the CD4 T-cell count response in the early month...

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

September 2003

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Anderegg N
Panayidou K
Abo Y
Alejos B
Althoff KN
Anastos K
Antinori A
Balestre E
Becquet R
Castagna A
Castelnuovo B
Chêne G
Coelho L
Collins IJ
Costagliola D
Crabtree-Ramírez B
Dabis F
d'Arminio Monforte A
Davies MA
De Wit S
Delpech V
De La Mata NL
Duda S
Freeman A
Gange SJ
Grabmeier-Pfistershammer K
Gunsenheimer-Bartmeyer B
Jiamsakul A
Kitahata MM
Law M
Manzardo C
McGowan C
Meyer L
Moore R
Mussini C
Nakigoz G
Nash D
Tek Ng O
Obel N
Pantazis N
Poda A
Raben D
Reiss P
Riggen L
Sabin C
d'Amour Sinayobye J
Sönnerborg A
Stoeckle M
Thorne C
Torti C
Twizere C
Wasmuth JC
Wittkop L
Wools-Kaloustian K
Yotebieng M
Kirk O
Egger M.

January 2018

Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.

Babiker, A
Darbyshire, J
Pezzotti, P
Porter, K
Prins, M
Sabin, C
Walker, A

January 2003

The effect of HIV infection duration and CD4 cell count on short-term CD4 response was evaluated in ...

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Wolbers, M
Babiker, A
Sabin, C
Young, J
Dorrucci, M
Chêne, G
Mussini, C
Porter, K
Bucher, H

January 2010

BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients

Bouteloup, V.
Sabin, C.
Mocroft, A.
Gras, L.
Pantazis, N.
Le Moing, V.
d'Arminio Monforte, A.
Mary-Krause, M.
Roca, B.
Miro, J. M.
Battegay, M.
Brockmeyer, N.
Berenguer, J.
Morlat, P.
Obel, N.
De Wit, S.
Faetkenheuer, G.
Zangerle, R.
Ghosn, J.
Perez-Hoyos, S.
Campbell, M.
Prins, M.
Chene, G.
Meyer, L.
Dorrucci, M.
Torti, C.
Thiebaut, R.

January 2017

ObjectivesThe aim of this work was to provide a reference for the CD4 T-cell count response in the e...

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa

Pantazis Nikos
Morrison Charles
Amornkul Pauli N.
Lewden Charlotte
Salata Robert A.
Minga Albert
Chipato Tsungai
Jaffe Harold
Lakhi Shabir
Karita Etienne
Porter Kholoud
Meyer Laurence
Touloumi Giota

March 2012

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa

Pantazis Nikos
Morrison Charles
Amornkul Pauli N.
Lewden Charlotte
Salata Robert A.
Minga Albert
Chipato Tsungai
Jaffe Harold
Lakhi Shabir
Karita Etienne
Porter Kholoud
Meyer Laurence
Touloumi Giota

March 2012

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India

Rajasekaran, S.
Jeyaseelan, L.
Raja, K.
Vijila, S.
Krithigaipriya, K. A.
Kuralmozhi, R.

October 2010

Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India

Rajasekaran, S.
Jeyaseelan, L.
Raja, K.
Vijila, S.
Krithigaipriya, K. A.
Kuralmozhi, R.

October 2010

Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Nikos Pantazis
Charles Morrison
Pauli N Amornkul
Charlotte Lewden
Robert A Salata
Albert Minga
Tsungai Chipato
Harold Jaffe
Shabir Lakhi
Etienne Karita
Kholoud Porter
Laurence Meyer
Giota Touloumi

It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicab...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

Available CD4 cell measurements, frequency and follow-up time of 1959 seroconverters from European and sub-Saharan African (SSA) cohorts.

Abstract

Extracted data

Available CD4 cell measurements, frequency and follow-up time of 1959 seroconverters from European and sub-Saharan African (SSA) cohorts.

Abstract

Extracted data

Related items

Related items